What Is a Skin Substitute in Wound Care? Types, Indications, and Billing
Skin substitutes explained — what CTPs are, when they're indicated for chronic wounds, the difference between amniotic/synthetic/xenograft products, and how they're billed.
Damon Ebanks
Medipyxis
What Is a Skin Substitute?
A skin substitute -- formally called a cellular and/or tissue-based product (CTP) -- is a bioengineered wound covering that promotes healing in chronic wounds that have not responded to standard care. Unlike traditional dressings that protect the wound bed, skin substitutes actively participate in the healing process by providing growth factors, extracellular matrix scaffolding, living cells, or a combination of these components.
Skin substitutes are not skin grafts. A skin graft is autologous tissue harvested from the patient's own body and transplanted to the wound site. Skin substitutes are manufactured products derived from human tissue, animal tissue, or synthetic materials that are applied to a wound to stimulate the patient's own healing mechanisms. The distinction matters clinically and for billing -- they are coded and covered differently.
What Are the Types of Skin Substitutes?
Skin substitutes fall into four broad categories based on their source material:
Amniotic membrane products. Derived from donated human placental tissue -- specifically the amnion and chorion membranes. These products are rich in growth factors, collagen, and anti-inflammatory cytokines. They are the most commonly used CTPs in outpatient wound care. Examples include dehydrated human amnion/chorion membrane (dHACM) products.
Allograft (human-derived) products. Sourced from donated human skin tissue, typically from cadaveric donors. These provide a dermal matrix and, in some cases, living cells that integrate with the wound bed. They are processed to remove cellular components that would cause rejection while preserving the structural matrix.
Xenograft (animal-derived) products. Made from animal tissue -- most commonly porcine (pig) or bovine (cow) sources. These provide a collagen scaffold that supports the patient's own cell migration and tissue formation. They are fully absorbed by the body during the healing process.
Synthetic products. Engineered from biocompatible materials without human or animal tissue. These provide a structural scaffold for cell migration and wound closure. They carry no risk of disease transmission and have no donor-supply constraints.
When Are Skin Substitutes Indicated?
Skin substitutes are not first-line treatment. They are indicated for chronic wounds that have failed conservative care -- specifically:
The wound must be chronic. The standard threshold is a wound that has not reduced in surface area by at least 50% after four weeks of appropriate standard wound care. This is the benchmark established by Medicare Local Coverage Determinations and is documented through serial wound measurements.
The wound type must be covered. Medicare LCDs for skin substitutes primarily cover diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). Some products have coverage for other wound types, but DFUs and VLUs are the primary covered indications.
The wound bed must be prepared. The wound must be debrided to viable tissue, free of clinical infection, and have adequate blood supply. Applying a skin substitute to a necrotic or infected wound bed is clinically inappropriate and will not be covered.
Conservative care must be documented. The medical record must show that appropriate standard care was rendered during the 4-week trial period -- wound bed preparation, appropriate dressings, offloading for DFUs, compression for VLUs, nutritional optimization, and infection management. Four weeks of inadequate care does not satisfy the requirement.
For the full set of documentation requirements, see our 4-week rule guide.
How Are Skin Substitutes Billed?
Skin substitute billing has two components that are submitted together:
Application CPT codes. The application of the product is billed using CPT codes 15271-15278. The specific code depends on the wound location (trunk/arms/legs vs. face/scalp/eyelids/hands/feet/genitalia) and the wound size. Codes 15271 and 15275 cover the first 25 sq cm; codes 15272 and 15276 are add-on codes for each additional 25 sq cm.
Product Q-codes. The product itself is billed separately using a HCPCS Q-code assigned to each specific skin substitute product. The Q-code identifies the product, and the units billed correspond to the amount of product applied (typically measured in square centimeters). Each product has its own Q-code -- there is no generic code. Using the wrong Q-code will result in denial.
Both components -- application and product -- must be supported by the same documentation: wound measurements, wound bed status, conservative care failure, and medical necessity narrative.
For a full list of current skin substitute Q-codes and their pricing, see our Q-code reference. For a detailed billing walkthrough, see our skin substitute billing guide. For patient-facing guidance on whether a wound qualifies for skin substitute treatment, see our qualification FAQ.